Cardinal Health (CAH) vs McKesson (MCK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Cardinal Health (CAH) has outperformed McKesson (MCK) over the past year, gaining 30.2% versus a gain of 23.5%. Over five years, CAH leads with a +473.1% price change compared with +382.6% for MCK. McKesson is the larger company by market cap ($123.47 billion vs $63.06 billion), about 2.0 times the size, while Cardinal Health is growing revenue faster (+14.2% vs +12.4%).
On valuation, Cardinal Health trades at a lower forward P/E (18.9x vs 20.4x for McKesson). Cardinal Health offers the higher dividend yield (0.75% vs 0.32%). McKesson converts more of its revenue into profit, with a net margin of 1.2% versus 0.7%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CAH | MCK |
|---|---|---|
| Share price | $272.81 | $1,069.43 |
| Market cap | $63.06B | $123.47B |
| 1-day change | +0.17% | +0.68% |
| YTD return | +32.75% | +30.37% |
| 1-year return | +30.23% | +23.49% |
| 5-year return | +473.13% | +382.57% |
| P/E ratio (TTM) | 35.29 | 27.58 |
| Forward P/E | 18.89 | 20.39 |
| EPS (TTM) | $7.73 | $38.77 |
| Dividend yield | 0.75% | 0.32% |
| Annual dividend | $2.05 | $3.40 |
| Revenue (latest FY) | $254.25B | $403.43B |
| Revenue growth (YoY) | +14.23% | +12.36% |
| Net income (latest FY) | $1.71B | $4.76B |
| Gross margin | 3.84% | 3.61% |
| Operating margin | 1.03% | 1.54% |
| Net margin | 0.67% | 1.18% |
| 52-week high | $286.29 | $1,121.50 |
| 52-week low | $180.45 | $723.68 |
| Distance from 52-week high | -4.71% | -4.64% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +8.09% | +8.57% |
| Average volume | 1.72M | 790.59K |
| Shares outstanding | 231.14M | 115.46M |
| Employees | 58,788 | 41,600 |
| Sector | Health Care | Health Care |
| Industry | Other Pharmaceuticals | Other Pharmaceuticals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Cardinal Health trades at a higher earnings multiple (35.3x vs 27.6x trailing P/E).
About Cardinal Health
CAH stock →Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally.
Health Care · Other Pharmaceuticals · 58,788 employees
About McKesson
MCK stock →McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions.
Health Care · Other Pharmaceuticals · 41,600 employees
CAH vs MCK FAQ
Which is bigger, Cardinal Health or McKesson?
McKesson (MCK) is larger, with a market capitalization of $123.47B compared with $63.06B for Cardinal Health (CAH).
Which stock has performed better over the past year, CAH or MCK?
CAH returned +30.23% over the past 12 months, compared with +23.49% for MCK (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CAH or MCK?
MCK has the lower trailing P/E at 27.6, versus 35.3 for CAH. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Cardinal Health or McKesson?
Cardinal Health has the higher yield at 0.75%, compared with 0.32% for McKesson.
Are Cardinal Health and McKesson in the same industry?
Yes. Both are classified in the Other Pharmaceuticals industry within the Health Care sector.